The Glucose Stabiliser in the U.S. is Designed to Control Blood Sugar and Weight Without Prescriptions, The Glucose Stabiliser is a Natural Silica-Based Treatment.

November 10th, 2023

Sigrid Therapeutics has officially launched the Glucose Stabiliser, an over-the-counter Type 2 diabetes treatment that can lower blood sugar and reduce caloric intake from fats and carbs. With about 1 in every 10 Americans facing a Type 2 diagnosis and the ever-growing popularity of a class of drugs used for weight loss for the general population, Sigird’s strategic launch into the U.S. market could not have come at a better time.

The supplement, taken before your two biggest meals of the day, comes after over 10 years of research when Co-Founder, Professor Tore Bengtsson, discovered improvements in metabolic disorder measurements after ingesting engineered silica particles. The technology is 100% natural since it is made of one of the most abundant resources on the planet, Silica.

The Glucose Stabiliser contains SiPore® technology discovered in 2008 that has proven to lower blood sugar, minimize bloating, keep you feeling fuller longer, curve appetite, and in effect aid in weight loss. Research shows users with Type 2 Diabetes saw a 40% larger HbA1c reduction compared to Metformin in half the time.

Composed of micron-sized silica particles that work inside the gut and nowhere else, the particles work as a molecular sieve by mechanically separating digestive enzymes from undigested food. The captured enzymes are responsible for breaking down complex carbohydrates and fats, and in effect, slowing down food digestion. With a slower digestion process, those using the glucose stabiliser can expect to feel full longer, lose weight and lower cholesterol all while continuing to live their lives to the fullest without restriction. While many prescribed diabetes medications come with a long list of side effects, the glucose stabiliser has no side effects.

While the diabetic implications are considerable, it’s also an excellent option for non-diabetics who would be interested in trying out the popular weight-loss prescriptions but are put off by the cost or the needles. By functioning in a similar way without the side effects of the drug in the bloodstream since it’s administered orally and stays in the gut, it’s a suitable option for those seeking general wellness and weight loss. Similarly, it’s the perfect companion to those coming off the drugs who fear a rebound weight gain.  

“The Glucose Stabiliser is representative of Sigrid’s mission of empowering those looking to transform their metabolism for the better in an affordable and approachable manner,” said Sana Alajmovic,” CEO of Sigrid Therapeutics. “After seeing my father transition from having difficulty controlling his blood sugar to developing Type 2 Diabetes, it is a personal undertaking just as much as it is professional to develop innovative treatments that allow users to continue living their life to the fullest, without having to drastically change their lifestyle.

Pricing for the Glucose Stabiliser starts at $99 a bottle and can now be purchased online at sigridstabiliser.com.

About Sigrid Therapeutics

Sigrid Therapeutics is a Swedish-based biotechnology company dedicated to revolutionizing obesity and diabetes management through its innovative SiPore® technology. The company’s flagship product, SiPore21®, is currently in SHINE clinical trials, offering a natural, non-drug solution for prediabetes progression and weight control. With a focus on impactful innovation, Sigrid Therapeutics is committed to enhancing the well-being of individuals worldwide. For more information visit sigridstabiliser.com.